Recombinant Vibrio cholerae serotype O1 Queuine tRNA-ribosyltransferase (tgt)

Shipped with Ice Packs
In Stock

Description

Key Features:

  • Storage: Stable at -20°C for short-term storage; long-term conservation requires -80°C .

  • Purity: >85% as verified by SDS-PAGE .

  • Sequence: Comprises 295 amino acids with a predicted molecular weight of ~33 kDa. A partial sequence is provided below:

Residues 1–50Residues 51–100Residues 101–150
MKLKFELKKK......GQLIFERGTV......QILLGNTFHL...

Full sequence available in .

Functional Role in tRNA Modification

Tgt modifies guanine to queuosine (Q34) in tRNAs with GUN anticodons (e.g., tRNA<sup>Tyr</sup>, tRNA<sup>His</sup>, tRNA<sup>Asn</sup>, tRNA<sup>Asp</sup>) . This modification:

  • Enhances Translational Efficiency: Q34 optimizes decoding of tyrosine codons (TAT/TAC), reducing ribosome stalling during antibiotic stress .

  • Regulates Stress Responses: Q34 modification fine-tunes the translation of transcripts with TAT codon bias, such as rsxA (an anti-SoxR factor), thereby modulating oxidative stress responses .

Table 1: Key Discoveries Involving Recombinant Tgt

FindingMethodologyImpactSource
Tgt deletion (Δtgt) reduces aminoglycoside toleranceCompetitive growth assays, proteomicsΔtgt strains show impaired growth under tobramycin stress due to mistranslation and oxidative stress sensitivity .
Q34 modification biases translation toward TAT codonsRibosome profiling, luciferase reportersTAT-rich transcripts (e.g., rsxA) are overexpressed in Δtgt, suppressing SoxR-regulated oxidative stress genes .
CRP represses tgt transcriptionTranscriptomics, promoter analysisCRP-mediated repression links Tgt expression to carbon metabolism .
Δtgt strains exhibit UV resistanceUV survival assaysEnhanced DNA repair in Δtgt correlates with TAT-biased translation of repair factors .

Applications in Antimicrobial Research

Recombinant Tgt serves as a tool to study:

  • Translational Regulation: How codon usage bias influences antibiotic tolerance .

  • Stress Adaptation: Role of tRNA modifications in bacterial survival under oxidative or DNA-damaging conditions .

  • Drug Target Exploration: Tgt inhibition could sensitize V. cholerae to aminoglycosides .

Regulatory and Environmental Modulation

  • Induction by Tobramycin: Sub-inhibitory concentrations upregulate tgt via the stringent response pathway .

  • Repression by CRP: The carbon catabolite regulator CRP binds near the tgt promoter, linking metabolism to tRNA modification .

Future Directions

  • Mechanistic Studies: Elucidate how Q34 fine-tunes stop-codon readthrough and mistranslation .

  • Therapeutic Development: Screen for Tgt inhibitors to enhance aminoglycoside efficacy .

Product Specs

Form
Lyophilized powder. Note: We will prioritize shipping the format we have in stock. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery times. Note: All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance, as additional fees apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to ensure contents are at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
tgt; VC0395_A0270; VC395_0758; Queuine tRNA-ribosyltransferase; EC 2.4.2.29; Guanine insertion enzyme; tRNA-guanine transglycosylase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-379
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio cholerae serotype O1 (strain ATCC 39541 / Classical Ogawa 395 / O395)
Target Names
tgt
Target Protein Sequence
MKLKFELKKK NGNARRGQLI FERGTVQTPA FMPVGTYGTV KGMTPEEVKE TGAQILLGNT FHLWLRPGQE VMKMHGDLHD FMNWQGPILT DSGGFQVFSL GDIRKITEEG VHFRNPVNGD KIFMDAEKSM EIQKDLGSDI VMIFDECTPY PATHDEAKKS MEMSLRWAKR SRDHFDKLEN PNNLFGIVQG GVYEDLRDVS VKGLTEIGFD GYAVGGLAVG EPKEDMHRVL EHTCPQLPED KPRYLMGVGK PEDLVEGVRR GIDMFDCVMP TRNARNGHLF VTGGVIKIRN AAHKTDTTPL DLHCDCYTCK NYSKSYLHHL DRCNEILGAR LNTIHNLRYY QRLMESIRKA IDEDRFDQFV AEFYARRNRE VPPLQKDKA
Uniprot No.

Target Background

Function
Queuine tRNA-ribosyltransferase (tgt) catalyzes the replacement of a guanine (G) with the queuine precursor 7-aminomethyl-7-deazaguanine (PreQ1) at position 34 (wobble position) in tRNAs with GU(N) anticodons (tRNA-Asp, -Asn, -His, and -Tyr). This occurs via a double-displacement mechanism. The active site nucleophile attacks C1' of nucleotide 34, removing the guanine base and forming a covalent enzyme-RNA intermediate. The active site proton acceptor deprotonates PreQ1, enabling it to attack the ribose C1' and form the product. After dissociation, two further enzymatic reactions convert PreQ1 to queuine (Q), resulting in the hypermodified nucleoside queuosine (7-(((4,5-cis-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-7-deazaguanosine).
Database Links
Protein Families
Queuine tRNA-ribosyltransferase family

Q&A

What is the primary function of Queuine tRNA-ribosyltransferase in Vibrio cholerae?

Queuine tRNA-ribosyltransferase (Tgt) in Vibrio cholerae catalyzes the exchange of guanine (G) with queuosine (Q) at the wobble position of tRNAs with GUN anticodons, specifically tRNA-Asp, -Asn, -His, and -Tyr. This post-transcriptional modification generates hypermodified nucleosides called queuosine (Q), which significantly impacts the efficiency of codon decoding during translation. Research has demonstrated that in V. cholerae, Tgt particularly affects the decoding efficiency at tyrosine TAT and TAC codons. The Q modification serves as a regulatory mechanism that can reprogram translation in response to environmental conditions, influencing protein synthesis patterns in the bacterium .

How does tgt expression relate to Vibrio cholerae pathogenicity?

While not directly involved in primary virulence factor production, tgt plays an important role in V. cholerae's stress response mechanisms that may indirectly influence pathogenicity. The tgt gene is required for optimal growth of V. cholerae when exposed to sub-lethal concentrations of aminoglycosides, indicating its importance in antibiotic stress responses. Proteomics analyses have revealed that Q modification impacts the translation of proteins involved in oxidative stress response, including the anti-SoxR factor RsxA. When tgt is absent, RsxA is better translated, leading to decreased expression of genes in the SoxR oxidative stress regulon . This connection between tRNA modification and stress response pathways suggests that tgt may contribute to bacterial adaptation during host infection, where both antibiotic and oxidative stresses are encountered.

What is the relationship between tgt and queuosine in bacterial systems compared to human cells?

In both bacterial and human systems, tgt/QTRT1 functions to incorporate queuosine into specific tRNAs, but with notable differences in enzyme structure and queuine acquisition. In V. cholerae and other bacteria, the Tgt enzyme functions as a single protein that catalyzes the exchange of guanine with a precursor of queuine (preQ1), which is later modified to form queuosine. Bacteria synthesize queuine de novo through a multi-step enzymatic pathway. In contrast, human cells utilize a heterodimeric enzyme complex where queuine tRNA-ribosyltransferase (QTRT-1) interacts with queuine tRNA-ribosyltransferase subunit QTRTD1 to form an active enzyme . Humans cannot synthesize queuine and must recover it from either ingested food or gut flora through a dedicated transporter system . This fundamental difference in queuine acquisition and enzyme structure represents a potential target for antimicrobial development that could selectively target bacterial systems.

How can researchers detect and quantify queuosine modification in tRNAs from Vibrio cholerae?

Two complementary approaches are commonly used to detect and quantify queuosine modifications in V. cholerae tRNAs. The first method involves mass spectrometry-based detection after nucleoside digestion. tRNA-enriched RNA fractions are isolated using TRIzol reagent and purified to eliminate contaminating DNA. These purified RNA samples are then digested to single nucleosides using nucleoside digestion enzymes. The resulting nucleoside mixture is analyzed by mass spectrometry to detect and quantify queuosine . The second approach utilizes a sequencing-based method that takes advantage of the chemical properties of queuosine. RNA samples are subjected to oxidation by NaIO₄, which creates strand breaks at modified nucleosides during reverse transcription. This results in deletion signatures that can be detected by high-throughput sequencing. After library preparation and sequencing, deletion scores are calculated as the number of deletions divided by the number of matching nucleotides at a given position . Using both approaches provides robust verification of queuosine presence and abundance in specific tRNAs.

What are the optimal conditions for expressing recombinant Vibrio cholerae tgt in heterologous systems?

For optimal expression of recombinant V. cholerae tgt in heterologous systems, several key parameters must be considered. When using E. coli as an expression host, the nirB promoter has been shown to be highly effective for regulated expression. Under this promoter, protein expression is significantly induced when bacteria are grown under low aeration conditions, which activates the anaerobically responsive nirB promoter . For experimental protocols, bacterial cultures should be diluted 1:1000 in appropriate media and grown aerobically at 37°C with 180 rpm shaking until reaching an OD₆₀₀ of 0.5, followed by a shift to microaerobic conditions to induce expression . Alternatively, the cholera toxin gene promoter (pctx) has also been used successfully for heterologous gene expression in V. cholerae. This can be achieved by amplifying the 190-bp sequence located immediately upstream of the ctx structural region, using primers that incorporate appropriate restriction sites (such as XbaI and NdeI) for subsequent cloning . When analyzing protein expression, Western blotting with specific antibodies against tgt or fusion tags provides a reliable method for detecting and quantifying the recombinant protein.

What plasmid-based systems are available for studying tgt activity in Vibrio cholerae?

Several plasmid-based systems have been developed for studying tgt activity in V. cholerae. For expression studies, plasmids containing the E. coli nirB promoter have proven effective for regulated expression of heterologous proteins, including enzymes like tgt. The plasmid pTETnir15 has been successfully used to express proteins in V. cholerae strain IEM101, with expression levels being highest under low aeration conditions . For investigating tgt function in relation to phage replication, plasmid-based CTX phage replication systems support the replication of various CTX phages, which could be adapted for tgt studies . When studying the relationship between tgt and tRNA modification, researchers can utilize specialized plasmids containing reporter constructs with biased codon usage (particularly for tyrosine TAT and TAC codons) to measure the impact of tgt activity on translational efficiency . For achieving stable maintenance in V. cholerae, these plasmids should contain compatible origins of replication and appropriate antibiotic resistance markers. When electroporating these constructs into V. cholerae strains, optimal conditions include using cells harvested at mid-log phase (OD₆₀₀ of 0.4-0.6), washing with ice-cold 2mM CaCl₂/10% glycerol solution, and applying a field strength of 1.8kV/cm.

How does tgt function contribute to aminoglycoside tolerance in Vibrio cholerae?

The tgt gene plays a critical role in aminoglycoside tolerance in V. cholerae through translational reprogramming mechanisms. Research has demonstrated that tgt is required for optimal growth when V. cholerae is exposed to sub-lethal concentrations of aminoglycosides such as tobramycin . This tolerance mechanism operates through the Q modification of tRNAs, which affects translational efficiency in a codon-specific manner. Q modification particularly impacts the decoding of tyrosine TAT and TAC codons, leading to differential translation of proteins with biased codon usage. Proteomics analyses revealed that in the absence of tgt, the anti-SoxR factor RsxA (which displays a bias toward tyrosine TAT codons) is more efficiently translated . This increased RsxA production leads to decreased expression of genes in the SoxR regulon, which includes oxidative stress response factors that may contribute to aminoglycoside tolerance. Additionally, in silico analysis identified several DNA repair factors with biased tyrosine codon usage that may be subject to tgt-dependent translational regulation . These "modification tunable transcripts" likely play central roles in the bacterial response to antibiotic stress, allowing V. cholerae to adapt to aminoglycoside exposure through fine-tuned regulation of stress response pathways.

What is the relationship between tgt function and CTX phage replication in Vibrio cholerae O1?

The relationship between tgt function and CTX phage replication in V. cholerae O1 represents an intriguing area of investigation, though direct experimental evidence linking these processes is still emerging. CTX phages carry the cholera toxin genes critical for V. cholerae pathogenicity, and their replication mechanisms are essential for horizontal transfer of virulence factors. Both classical and El Tor biotype V. cholerae O1 strains are generated by lysogenization with biotype-specific CTX phages . Laboratory evidence has shown that CTX-1 (El Tor-specific), CTX-cla (classical-specific), CTX-2, and CTX-O139 phages can replicate using a plasmid-based CTX phage replication system . Given that tgt affects translational efficiency in a codon-specific manner, it could potentially influence the expression of phage proteins involved in replication, particularly those with biased tyrosine codon usage. The regulated expression of tgt in response to environmental conditions might serve as a mechanism for controlling phage replication under specific circumstances. Further research using tgt mutants to assess CTX phage replication efficiency would provide valuable insights into this potential regulatory relationship.

Can Vibrio cholerae tgt be utilized as part of a live-attenuated vaccine development strategy?

V. cholerae tgt has significant potential as part of a live-attenuated vaccine development strategy, particularly as a mechanism for modulating the expression of heterologous antigens. Attenuated V. cholerae strains have already been successfully used as carriers for the expression of heterologous antigens, such as fragment C from tetanus toxin (TetC) and tracheal colonization factor from Bordetella pertussis (Tcf) . By placing heterologous genes under the control of promoters like the E. coli nirB promoter or the cholera toxin gene promoter (pctx), high levels of protein expression can be achieved . The tgt enzyme's role in translational regulation could be leveraged to optimize antigen expression in vaccine strains. By engineering constructs with specific codon usage patterns (particularly for tyrosine codons), researchers could potentially create vaccine strains where antigen expression is regulated by tgt activity and responsive to environmental conditions. This would allow for controlled antigen production in specific host environments. Additionally, since tgt is involved in stress response mechanisms, modulating its activity could potentially enhance the immunogenicity of live-attenuated vaccines by influencing the bacterial stress response during host colonization.

What are common challenges in purifying active recombinant Vibrio cholerae tgt enzyme?

Purifying active recombinant V. cholerae tgt enzyme presents several technical challenges that researchers must address. One significant obstacle is protein solubility—tgt can form inclusion bodies when overexpressed in heterologous systems like E. coli. To overcome this, expression conditions should be optimized by using lower growth temperatures (16-25°C) and inducer concentrations, or by employing solubility-enhancing fusion tags such as MBP (maltose-binding protein) or SUMO. Another challenge is maintaining enzymatic activity during purification. The tgt enzyme requires proper folding and may be sensitive to oxidation of cysteine residues. Purification buffers should contain reducing agents like DTT or β-mercaptoethanol (1-5 mM) and be performed under controlled temperature conditions (4°C). Protein stability can be enhanced by including glycerol (10-20%) in storage buffers. Additionally, since tgt catalyzes the exchange of guanine with queuine, the purification process must ensure removal of nucleic acids that might interfere with subsequent activity assays. This can be achieved through high-salt washes (0.5-1M NaCl) during affinity chromatography steps. For assessing enzyme activity, researchers must develop appropriate assays that can detect the guanine-queuine exchange reaction, which often requires radiolabeled substrates or sensitive mass spectrometry-based methods.

How can researchers address the variability in tgt expression under different growth conditions?

Addressing variability in tgt expression under different growth conditions requires systematic optimization and standardization of experimental protocols. The expression of tgt in V. cholerae is known to be regulated by environmental conditions, particularly oxygen levels . When using the nirB promoter system, consistent low-oxygen conditions must be maintained for reproducible expression. This can be achieved using specialized culture vessels with controlled oxygen tension or by standardizing culture volumes and flask sizes to ensure consistent aeration. Growth phase significantly impacts expression levels, with optimal expression typically occurring in mid-logarithmic phase (OD₆₀₀ of 0.4-0.6). Researchers should establish precise harvesting time points based on growth curves rather than fixed incubation times. Media composition also affects tgt expression—rich media like LB may yield different expression patterns compared to minimal media. Standardizing media preparation with high-quality components helps reduce batch-to-batch variation. Temperature fluctuations during growth can dramatically alter expression profiles; maintaining precise temperature control (±0.5°C) throughout the experiment is essential. For quantitative studies, normalization approaches using internal reference genes that remain stable under the tested conditions should be employed when measuring tgt expression by qRT-PCR or Western blotting. Finally, researchers should consider using reporter systems (such as tgt promoter-GFP fusions) to monitor expression dynamics in real-time across different conditions.

What strategies can overcome the challenges in studying tgt-dependent tRNA modifications in vivo?

Studying tgt-dependent tRNA modifications in vivo presents unique challenges that require specialized approaches. One major obstacle is the low abundance of modified tRNAs, which necessitates sensitive detection methods. Researchers can overcome this by employing Northern blot analysis with oligonucleotide probes specific for Q-modified versus unmodified tRNAs, coupled with enrichment of the tRNA fraction using commercially available kits or TRIzol-based methods optimized for small RNAs . Another approach involves mass spectrometry-based techniques, which require digestion of RNA samples to nucleosides followed by LC-MS/MS analysis using appropriate internal standards for quantification . The periodate oxidation-based sequencing approach represents an additional powerful tool, where NaIO₄ treatment (45 mM in 50 mM AcONa pH 5.2) creates strand breaks at modified nucleosides during reverse transcription, generating detectable deletion signatures . For in vivo studies, genetic manipulation strategies are essential. Creating precise tgt deletion mutants using λ-Red recombineering or CRISPR-Cas9 systems allows for clean genetic backgrounds when studying the effects of tgt absence. Complementation studies should utilize inducible promoter systems with titratable expression to avoid artifacts from overexpression. To address potential polar effects, researchers should design constructs that maintain the integrity of adjacent gene expression. Finally, functional studies of tgt activity should incorporate pulse-chase labeling with radioactive or stable isotope-labeled precursors to track the dynamic incorporation of Q modifications under varying environmental conditions.

How might tgt function in Vibrio cholerae relate to potential antimicrobial development strategies?

The function of tgt in V. cholerae presents several promising avenues for antimicrobial development. Since tgt is required for optimal growth under aminoglycoside stress conditions, targeting this enzyme could potentially enhance the efficacy of existing aminoglycoside antibiotics through combination therapy approaches . Structure-based drug design targeting the active site of bacterial tgt could yield selective inhibitors that do not affect the human QTRT1 enzyme due to structural differences between bacterial and human enzymes. Crystallographic studies have revealed the catalytic pocket of bacterial tgt enzymes, facilitating rational design of inhibitors that could interfere with the guanine-queuine exchange reaction. The involvement of tgt in translational stress responses suggests that inhibitors could potentially disrupt V. cholerae's ability to adapt to host environments or antibiotic exposure . High-throughput screening of chemical libraries against purified V. cholerae tgt could identify lead compounds that selectively inhibit the bacterial enzyme. Subsequent medicinal chemistry optimization would focus on improving pharmacokinetic properties while maintaining selectivity. Additionally, since tgt affects the translation of proteins with specific codon biases, inhibitors could potentially disrupt the expression of key bacterial proteins involved in stress responses or virulence, creating a novel class of pathogen-specific antimicrobials with potentially lower resistance development rates than conventional antibiotics.

What are the implications of tgt-mediated translational reprogramming for bacterial adaptation to environmental stresses?

Tgt-mediated translational reprogramming represents a sophisticated mechanism for bacterial adaptation to environmental stresses. Research has shown that Q modification impacts the efficiency of decoding specific codons, particularly tyrosine TAT and TAC codons . This creates a regulatory system where proteins with biased codon usage become differentially translated based on the activity of tgt and the prevalence of Q-modified tRNAs. Proteomics analyses revealed that the anti-SoxR factor RsxA, which displays a bias toward tyrosine TAT codons, is better translated in the absence of tgt, leading to decreased expression of genes in the SoxR oxidative stress regulon . This mechanism allows for rapid adaptation to changing environmental conditions without requiring transcriptional changes. In silico analysis identified numerous "modification tunable transcripts" with biased codon usage, including DNA repair factors that likely play central roles in stress responses . The environmental regulation of tgt expression creates a scenario where specific stressors can trigger translational reprogramming by altering tgt activity or Q modification levels. This represents a previously underappreciated layer of bacterial gene regulation that operates at the translational level. Further research into this mechanism could reveal how bacteria integrate environmental signals to fine-tune their proteome through codon-biased translation, potentially explaining aspects of bacterial persistence, antibiotic tolerance, and adaptation to host environments that cannot be accounted for by transcriptional regulation alone.

Could the tgt-dependent translational control mechanism in Vibrio cholerae inform our understanding of similar processes in other pathogenic bacteria?

The tgt-dependent translational control mechanism in V. cholerae likely represents a conserved regulatory strategy that could significantly expand our understanding of post-transcriptional regulation in diverse bacterial pathogens. The core function of tgt—catalyzing the exchange of guanine with queuine in specific tRNAs—is conserved across many bacterial species, suggesting that tgt-mediated translational control may be widespread. Comparative genomics studies could identify bacterial species with similar patterns of biased codon usage in stress response genes, potentially revealing common targets of tgt-dependent regulation. In V. cholerae, tgt affects aminoglycoside tolerance and oxidative stress responses , but in other pathogens, it may influence different aspects of virulence or stress adaptation. For instance, in intracellular pathogens, tgt might regulate genes involved in phagosomal escape or nutrient acquisition, while in biofilm-forming bacteria, it could modulate the expression of matrix production components. The discovery that environmental conditions regulate tgt expression in V. cholerae suggests that different pathogens might have evolved unique regulatory mechanisms for tgt that reflect their specific ecological niches. Systems biology approaches combining transcriptomics, proteomics, and tRNA modification profiling across multiple bacterial species could reveal both conserved and species-specific aspects of tgt-dependent regulation. This comparative approach would not only advance our fundamental understanding of bacterial gene regulation but could also identify new targets for broad-spectrum or pathogen-specific antimicrobial strategies that disrupt this critical translational control mechanism.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.